Primary aldosteronism is a common cause of hypertension and is a risk factor for
cardiovascular and renal morbidity and mortality, via mechanisms mediated by both …

Background: Confirmatory tests are recommended for diagnosing primary aldosteronism,
but the supporting evidence is unclear. Methods: We searched Medline, EMBASE, and the …

Primary aldosteronism (PA) is associated with higher cardiovascular morbidity and mortality
rates than essential hypertension. The Japan Endocrine Society (JES) has developed an …

Primary aldosteronism confers a higher risk of stroke, atrial fibrillation, and cardiovascular
disease than blood pressure matched essential hypertension. It is the most common …

Primary aldosteronism (PA) is the most common potentially curable form of hypertension.
The overproduction of aldosterone leads to an increased risk of cardiovascular and …

Primary aldosteronism (PA) is the most common endocrine cause of secondary
hypertension and is associated with a high risk of cardiovascular disease in the general …

Purpose To evaluate whether the clinical, biochemical and radiological features of patients
with primary aldosteronism (PA) can predict both main subtypes of PA. Methods A …

Objective To evaluate the indication and the resources for the screening/diagnosis of
primary aldosteronism (PA) in Endocrinology units in Spain. Material and methods An …

Objective The saline suppression test (SST) and captopril challenge test (CCT) are
commonly used confirmatory tests for primary aldosteronism (PA). Seated SST (SSST) has …

Aldosterone is a mineralocorticoid hormone that increases sodium (ie, salt) and water (ie,
fluid) retention, ultimately increasing blood pressure.[1] Aldosterone also increases …